关注
Vijay Kumar Prajapati
Vijay Kumar Prajapati
Associate Professor, Department of Biochemistry, University of Delhi South Campus
在 south.du.ac.in 的电子邮件经过验证
标题
引用次数
引用次数
年份
Exploring dengue genome to construct a multi-epitope based subunit vaccine by utilizing immunoinformatics approach to battle against dengue infection
M Ali, RK Pandey, N Khatoon, A Narula, A Mishra, VK Prajapati
Scientific reports 7 (1), 9232, 2017
3462017
Efficacy of miltefosine in the treatment of visceral leishmaniasis in India after a decade of use
S Sundar, A Singh, M Rai, VK Prajapati, AK Singh, B Ostyn, M Boelaert, ...
Clinical infectious diseases 55 (4), 543-550, 2012
3392012
Exploring Leishmania secretory proteins to design B and T cell multi-epitope subunit vaccine using immunoinformatics approach
N Khatoon, RK Pandey, VK Prajapati
Scientific reports 7 (1), 8285, 2017
3172017
Novel Immunoinformatics Approaches to Design Multi-epitope Subunit Vaccine for Malaria by Investigating Anopheles Salivary Protein
RK Pandey, TK Bhatt, VK Prajapati
Scientific reports 8 (1), 1125, 2018
2232018
Targeted killing of Leishmania donovani in vivo and in vitro with amphotericin B attached to functionalized carbon nanotubes
VK Prajapati, K Awasthi, S Gautam, TP Yadav, M Rai, ON Srivastava, ...
Journal of antimicrobial chemotherapy 66 (4), 874-879, 2011
1722011
Evolutionary genomics of epidemic visceral leishmaniasis in the Indian subcontinent
H Imamura, T Downing, F Van den Broeck, MJ Sanders, S Rijal, S Sundar, ...
Elife 5, e12613, 2016
1672016
Drug susceptibility in Leishmania isolates following miltefosine treatment in cases of visceral leishmaniasis and post kala-azar dermal leishmaniasis
V Bhandari, A Kulshrestha, DK Deep, O Stark, VK Prajapati, V Ramesh, ...
PLoS neglected tropical diseases 6 (5), e1657, 2012
1232012
Molecular and immunological toxic effects of nanoparticles
RK Pandey, VK Prajapati
International journal of biological macromolecules 107, 1278-1293, 2018
1222018
Circulating MicroRNAs: potential and emerging biomarkers for diagnosis of human infectious diseases
P Verma, RK Pandey, P Prajapati, VK Prajapati
Frontiers in microbiology 7, 1274, 2016
1162016
Immunoinformatics approaches to design a novel multi-epitope subunit vaccine against HIV infection
RK Pandey, R Ojha, VS Aathmanathan, M Krishnan, VK Prajapati
Vaccine 36 (17), 2262-2272, 2018
1132018
Racial disparities in prostate cancer: a molecular perspective
A Bhardwaj, SK Srivastava, MA Khan, VK Prajapati, S Singh, JE Carter, ...
Frontiers in bioscience (Landmark edition) 22, 772, 2017
1022017
An oral formulation of amphotericin B attached to functionalized carbon nanotubes is an effective treatment for experimental visceral leishmaniasis
VK Prajapati, K Awasthi, TP Yadav, M Rai, ON Srivastava, S Sundar
Journal of Infectious Diseases 205 (2), 333-336, 2012
982012
High throughput virtual screening reveals SARS-CoV-2 multi-target binding natural compounds to lead instant therapy for COVID-19 treatment
B Naik, N Gupta, R Ojha, S Singh, VK Prajapati, D Prusty
International Journal of Biological Macromolecules 160, 1-17, 2020
952020
Antileishmanial activity of nano-amphotericin B deoxycholate
KD Manandhar, TP Yadav, VK Prajapati, S Kumar, M Rai, A Dube, ...
Journal of Antimicrobial Chemotherapy 62 (2), 376-380, 2008
952008
Designing B‐and T‐cell multi‐epitope based subunit vaccine using immunoinformatics approach to control Zika virus infection
R Kumar Pandey, R Ojha, A Mishra, V Kumar Prajapati
Journal of cellular biochemistry 119 (9), 7631-7642, 2018
942018
Differential expression of miRNA regulates T cell differentiation and plasticity during visceral leishmaniasis infection
RK Pandey, S Sundar, VK Prajapati
Frontiers in microbiology 7, 206, 2016
932016
Characterisation of antimony-resistant Leishmania donovani isolates: biochemical and biophysical studies and interaction with host cells
R Mukhopadhyay, S Mukherjee, B Mukherjee, K Naskar, D Mondal, ...
International journal for parasitology 41 (13-14), 1311-1321, 2011
932011
Drug targeting to infectious diseases by nanoparticles surface functionalized with special biomolecules
S Sundar, V Kumar Prajapati
Current medicinal chemistry 19 (19), 3196-3202, 2012
832012
Unusual case of resistance to amphotericin B in visceral leishmaniasis in a region in India where leishmaniasis is not endemic
P Srivastava, VK Prajapati, M Rai, S Sundar
Journal of clinical microbiology 49 (8), 3088-3091, 2011
782011
Global age-sex-specific mortality, life expectancy, and population estimates in 204 countries and territories and 811 subnational locations, 1950–2021, and the impact of the …
AE Schumacher, HH Kyu, A Aali, C Abbafati, J Abbas, ...
The Lancet 403 (10440), 1989-2056, 2024
772024
系统目前无法执行此操作,请稍后再试。
文章 1–20